PMPL Consortium Private Limited
About PMPL Consortium Private Limited
Data last updated:
PMPL Consortium Private Limited is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2014PTC270907. Its GSTIN is 07AAHCP8039N1ZS (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Prakash Chand Aggarwal and Archana Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 1664 Nangal Raya, New, Delhi, India – 110046.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressWz – 1664 Nangal Raya, New, Delhi, India – 110046
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of PMPL Consortium Private Limited FY 2025 filings available
PMPL Consortium Private Limited reported revenue of ₹2,564 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of PMPL Consortium Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 77% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of PMPL Consortium Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of PMPL Consortium Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of PMPL Consortium are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of PMPL Consortium Private Limited
PMPL Consortium Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fyodor Trade Plus Private Limited | ₹3,000 (FY 2025) | •••• | •••• | -91.0% | •••• | Pune, Maharashtra, India |
| El-Life Medi Pharma Limited | ₹3,000 (FY 2019) | •••• | •••• | -100.0% | •••• | Jaipur, Rajasthan, India |
| Genxbio Health Sciences Private Limited | ₹2,906 (FY 2025) | •••• | •••• | -87.0% | •••• | Delhi, India |
| German Health Care Private Limited | ₹2,872 (FY 2024) | •••• | •••• | 884.0% | •••• | Indore, Madhya Pradesh, India |
| Be Pellets Limited | ₹2,724 (FY 2025) | •••• | •••• | -100.0% | •••• | Chandigarh, India |
| PMPL Consortium Private Limited this company | ₹2,564 (FY 2024) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Mini Med Laboratories Pvt Ltd | ₹2,554 (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Ethico Pharma Private Limited | ₹2,303 (FY 2025) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Vama Healthcare Private Limited | ₹2,119 (FY 2024) | •••• | •••• | 172.0% | •••• | Mumbai, Maharashtra, India |
| Kanoy Industries Private Limited | ₹2,092 (FY 2025) | •••• | •••• | •••• | Charminar, Telangana, India | |
| Krislord Parenterals Private Limited | ₹2,081 (FY 2025) | •••• | •••• | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below PMPL Consortium by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of PMPL Consortium Private Limited
PMPL Consortium Private Limited is audited by ROHIT J AGGARWAL & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ROHIT J AGGARWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of PMPL Consortium Private Limited
PMPL Consortium has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Chand Aggarwal Also directs: Prakash Medisol Private Limited | Director | 26 Aug 2014 | 12 Years 1 Months | Current |
| Archana Aggarwal | Director | 26 Aug 2014 | 12 Years 1 Months | Current |
Ownership and Shareholding of PMPL Consortium Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of PMPL Consortium Private Limited
PMPL Consortium Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at PMPL Consortium Private Limited
Employment history and EPFO contributions of people linked to PMPL Consortium.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on PMPL Consortium Private Limited
PMPL Consortium Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Sudhakaran Sudhir Kumar ceased to be Director on 04 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for PMPL Consortium Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by PMPL Consortium Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of PMPL Consortium Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of PMPL Consortium Private Limited
PMPL Consortium has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCP8039N1ZS | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of PMPL Consortium Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PMPL Consortium Private Limited
PMPL Consortium is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 August 2014 (12+ years old) and is registered under CIN U33110DL2014PTC270907.
PMPL Consortium has 2 current directors:
- Prakash Chand Aggarwal - Director
- Archana Aggarwal - Director
The GSTIN of PMPL Consortium is 07AAHCP8039N1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of PMPL Consortium is U33110DL2014PTC270907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PMPL Consortium was incorporated on 26 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of PMPL Consortium by revenue are Fyodor Trade Plus Private Limited, El-Life Medi Pharma Limited, Genxbio Health Sciences Private Limited, German Health Care Private Limited, Be Pellets Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sudhakaran Sudhir Kumar ceased to be Director on 04 Jun 2018. Ajitesh Trehan ceased to be Director on 27 Mar 2017. Sanjay Sharma ceased to be Director on 27 Mar 2017. PMPL Consortium has 5 board changes on record in total.
The registered office of PMPL Consortium is at Wz – 1664 Nangal Raya, New, Delhi, India – 110046.
PMPL Consortium has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh.
PMPL Consortium operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. PMPL Consortium is not listed on any stock exchange. It is an unlisted company.